JOHN A DIGIGLIA

Allopathic & Osteopathic Physicians|Family Medicine LAKE CHARLES, LA NPI 1497717656

General Payments — all program years on this page

$3,144.25

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 174
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $301.57 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $301.5712

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Esperion Therapeutics, Inc. $160.884
Lilly USA, LLC $81.144
Acerta Pharma LLC $35.512
Phathom Pharmaceuticals, Inc. $22.941
Novo Nordisk AS $1.101

By program year

Program yearAmountRecords
2018 $679.3443
2019 $304.0515
2020 $237.2712
2021 $649.8242
2022 $549.9328
2023 $422.2722
2024 $301.5712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104283079 AstraZeneca Pharmaceuticals LP $20.05 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104589094 AstraZeneca Pharmaceuticals LP $15.46 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129433220 Esperion Therapeutics, Inc. $16.25 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129433222 Esperion Therapeutics, Inc. $110.53 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129433224 Esperion Therapeutics, Inc. $14.87 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129433226 Esperion Therapeutics, Inc. $19.23 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130818224 Novo Nordisk Inc $1.10 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135053108 Lilly USA, LLC $19.78 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135053110 Lilly USA, LLC $20.80 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135069387 Lilly USA, LLC $23.14 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135069389 Lilly USA, LLC $17.42 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151055969 Phathom Pharmaceuticals, Inc. $22.94 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.